How many insider trades does FilingIQ track for PRPO?

FilingIQ tracks 130 Form 4 insider transactions for PRPO (Precipio, Inc.), covering filings from Jul 3, 2017 onwards. 3 of those are dated within the last 90 days.

Are PRPO insiders net buyers or net sellers?

Across the full Form 4 history for PRPO, 47 transactions (36%) were open-market purchases and 17 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PRPO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is PRPO in?

Precipio, Inc. (PRPO) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $44.43M.

PRPO insider trading

NasdaqCM Healthcare

Precipio, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

130

Last 90 days

Buys / sells

36% / 13%

Market cap

$44.43M

About Precipio, Inc.

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Company website: www.precipiodx.com

PRPO insider activity at a glance

FilingIQ tracks 130 insider transactions for PRPO in filings since Jul 3, 2017. The most recent transaction is dated Jul 15, 2026.

Across the full history, 47 open-market purchases and 17 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PRPO insider trades is 62.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PRPO trades on FilingIQ Raw filings on SEC EDGAR

Latest PRPO Form 4 filings

Valauri Christina Rizopoulos

Valauri Christina Rizopoulos

Sabet Ahmed Zaki Chief Operating Officer

P Apr 10, 2026

ANDREWS RONALD ASBURY

A Jan 20, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for PRPO?: FilingIQ tracks 130 Form 4 insider transactions for PRPO (Precipio, Inc.), covering filings from Jul 3, 2017 onwards. 3 of those are dated within the last 90 days.
Are PRPO insiders net buyers or net sellers?: Across the full Form 4 history for PRPO, 47 transactions (36%) were open-market purchases and 17 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PRPO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is PRPO in?: Precipio, Inc. (PRPO) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $44.43M.

Methodology & sources

Every PRPO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.